WallStreetZenWallStreetZen

NYSE: WAT
Waters Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for WAT

Based on 19 analysts offering 12 month price targets for Waters Corp

Min Forecast
$370.00-21.43%
Avg Forecast
$461.37-2.02%
Max Forecast
$536.00+13.82%

Should I buy or sell WAT stock?

Based on 19 analysts offering ratings for Waters Corp.

Strong Buy
Strong Buy
10 analysts 52.63%
Buy
4 analysts 21.05%
Hold
5 analysts 26.32%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although WAT's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates WAT as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their WAT stock forecasts and price targets.

WAT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04
lockedlocked$00.00+00.00%2026-11-04Find Out Why
lockedlocked$00.00+00.00%2026-11-04Find Out Why
lockedlocked$00.00+00.00%2026-11-04
KeyBanc
Top 21%
80
Strong BuyMaintains$500.00+6.18%2026-11-04Find out why
Guggenheim
Top 2%
99
Strong BuyMaintains$490.00+4.06%2026-10-01Find out why
Goldman Sachs
Top 45%
56
Strong BuyMaintains$515.00+9.37%2026-09-21
UBS
Top 12%
89
Strong BuyUpgrades$490.00+4.06%2026-09-09Find out why
Piper Sandler
Top 1%
100
Strong BuyUpgrades$480.00+1.93%2026-08-27Find out why

1 of 2

Forecast return on equity

Is WAT forecast to generate an efficient return?

Company
13.79%
Industry
85.02%
Market
160.87%
WAT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is WAT forecast to generate an efficient return on assets?

Company
8.75%
Industry
14.68%
WAT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

WAT earnings per share forecast

What is WAT's earnings per share in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$14.74+509.05%
Avg 2 year Forecast
$16.68+589.24%
Avg 3 year Forecast
$18.78+676.13%
WAT's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

WAT revenue forecast

What is WAT's revenue in the next 3 years based on estimates from 27 analysts?

Avg 1 year Forecast
$6.5B+16.71%
Avg 2 year Forecast
$7.2B+28.92%
Avg 3 year Forecast
$7.7B+37.23%
WAT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

WAT earnings growth forecast

How is WAT forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
97.87%
Industry
21.7%
Market
32.69%
WAT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
WAT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
WAT's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

WAT revenue growth forecast

How is WAT forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
11.34%
Industry
6.53%
Market
12.33%
WAT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
WAT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

WAT vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
WAT$470.90$461.37-2.02%Strong Buy
NTRA$319.82$397.03+24.14%Strong Buy
IQV$274.53$310.25+13.01%Strong Buy
A$176.95$177.17+0.12%Strong Buy
IDXX$702.59$728.00+3.62%Buy
View Top Diagnostic & Research Stocks

Waters Stock Forecast FAQ

Is Waters Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 19 Wall Street analysts covering (NYSE: WAT) stock is to Strong Buy WAT stock.

Out of 19 analysts, 10 (52.63%) are recommending WAT as a Strong Buy, 4 (21.05%) are recommending WAT as a Buy, 5 (26.32%) are recommending WAT as a Hold, 0 (0%) are recommending WAT as a Sell, and 0 (0%) are recommending WAT as a Strong Sell.

If you're new to stock investing, here's how to buy Waters stock.

What is WAT's earnings growth forecast for 2026-2028?

(NYSE: WAT) Waters's forecast annual earnings growth rate of 97.87% is forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 21.7%, and it is also forecast to beat the US market's average forecast earnings growth rate of 32.69%.

Waters's earnings in 2026 is $98,214,000.On average, 27 Wall Street analysts forecast WAT's earnings for 2026 to be $1,448,622,131, with the lowest WAT earnings forecast at $1,391,822,863, and the highest WAT earnings forecast at $1,515,593,962. On average, 27 Wall Street analysts forecast WAT's earnings for 2027 to be $1,639,365,061, with the lowest WAT earnings forecast at $1,542,081,940, and the highest WAT earnings forecast at $1,746,142,574.

In 2028, WAT is forecast to generate $1,846,030,263 in earnings, with the lowest earnings forecast at $1,711,605,002 and the highest earnings forecast at $2,087,734,295.

What is WAT's revenue growth forecast for 2026-2028?

(NYSE: WAT) Waters's forecast annual revenue growth rate of 11.34% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6.53%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.33%.

Waters's revenue in 2026 is $5,610,362,000.On average, 27 Wall Street analysts forecast WAT's revenue for 2026 to be $643,574,331,432, with the lowest WAT revenue forecast at $618,609,780,396, and the highest WAT revenue forecast at $670,996,023,318. On average, 27 Wall Street analysts forecast WAT's revenue for 2027 to be $710,899,990,722, with the lowest WAT revenue forecast at $679,252,016,574, and the highest WAT revenue forecast at $760,239,378,990.

In 2028, WAT is forecast to generate $756,701,096,166 in revenue, with the lowest revenue forecast at $717,976,556,370 and the highest revenue forecast at $837,983,315,484.

What is WAT's forecast return on assets (ROA) for 2026-2029?

(NYSE: WAT) forecast ROA is 8.75%, which is lower than the forecast US Diagnostics & Research industry average of 14.68%.

What is WAT's Price Target?

According to 19 Wall Street analysts that have issued a 1 year WAT price target, the average WAT price target is $461.37, with the highest WAT stock price forecast at $536.00 and the lowest WAT stock price forecast at $370.00.

On average, Wall Street analysts predict that Waters's share price could fall to $461.37 by Nov 4, 2027. The average Waters stock price prediction forecasts a potential downside of 2.02% from the current WAT share price of $470.90.

What is WAT's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: WAT) Waters's current Earnings Per Share (EPS) is $2.42. On average, analysts forecast that WAT's EPS will be $14.74 for 2026, with the lowest EPS forecast at $14.16, and the highest EPS forecast at $15.42. On average, analysts forecast that WAT's EPS will be $16.68 for 2027, with the lowest EPS forecast at $15.69, and the highest EPS forecast at $17.77. In 2028, WAT's EPS is forecast to hit $18.78 (min: $17.41, max: $21.24).

What is WAT's forecast return on equity (ROE) for 2026-2029?

(NYSE: WAT) forecast ROE is 13.79%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.